Severity of Helicobacter pylori gastritis predicts duodenal ulcer recurrence. 1996

S Miehlke, and E Bayerdörffer, and N Lehn, and G A Mannes, and A Sommer, and W Höchter, and J Weingart, and E Bästlein, and R Hatz, and M Stolte
Dept. of Gastroenterology, Hepatology and Infectious Diseases, University Hospital, Magdeburg, Germany.

BACKGROUND Helicobacter pylori gastritis is suggested to be the underlying condition leading to duodenal ulcer disease. The aim of the study was to investigate the relationship between chronic active H. pylori gastritis and the risk of duodenal ulcer (DU) recurrence. METHODS One hundred and eighty-eight patients were followed up with regard to the evolution of their H. pylori gastritis after they had received antibacterial or acid-suppressing treatment for their DU. Four weeks, 1 year, and 2 years after treatment and in the case of DU recurrence several morphologic indicators of gastritis were studied histologically in the antrum and corpus. RESULTS In patients who were cured of H. pylori infection a significant and long-lasting regression of all gastritis variables were observed. patients with persistent H. pylori infection after antibacterial treatment showed only a temporary regression of all gastritis variables. In the overall group of patients who received acid-suppressive therapy there was no change in gastritis. However, in the subgroup of patients who received omeprazole monotherapy, no change in the antrum but a statistically significant increase of gastritis in the corpus was observed. The grade of antral gastritis at the end of treatment was significantly and positively correlated with the risk of DU recurrence and was independent of the kind of pretreatment (18.5% recurrences in grade-2 versus 86% in grade-4 gastritis). CONCLUSIONS The data show that the grade of gastritis is an important risk factor for duodenal ulcer recurrence. Cure of H. pylori infection is associated with healing of chronic H. pylori-associated gastritis. These data lend considerable support to the hypothesis that H. pylori gastritis is the most important factor among those leading to duodenal ulcer disease.

UI MeSH Term Description Entries
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D004381 Duodenal Ulcer A PEPTIC ULCER located in the DUODENUM. Curling's Ulcer,Curling Ulcer,Curlings Ulcer,Duodenal Ulcers,Ulcer, Curling,Ulcer, Duodenal,Ulcers, Duodenal
D005756 Gastritis Inflammation of the GASTRIC MUCOSA, a lesion observed in a number of unrelated disorders. Gastritides
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D016480 Helicobacter pylori A spiral bacterium active as a human gastric pathogen. It is a gram-negative, urease-positive, curved or slightly spiral organism initially isolated in 1982 from patients with lesions of gastritis or peptic ulcers in Western Australia. Helicobacter pylori was originally classified in the genus CAMPYLOBACTER, but RNA sequencing, cellular fatty acid profiles, growth patterns, and other taxonomic characteristics indicate that the micro-organism should be included in the genus HELICOBACTER. It has been officially transferred to Helicobacter gen. nov. (see Int J Syst Bacteriol 1989 Oct;39(4):297-405). Campylobacter pylori,Campylobacter pylori subsp. pylori,Campylobacter pyloridis,Helicobacter nemestrinae
D016481 Helicobacter Infections Infections with organisms of the genus HELICOBACTER, particularly, in humans, HELICOBACTER PYLORI. The clinical manifestations are focused in the stomach, usually the gastric mucosa and antrum, and the upper duodenum. This infection plays a major role in the pathogenesis of type B gastritis and peptic ulcer disease. Infections, Helicobacter,Helicobacter Infection,Infection, Helicobacter

Related Publications

S Miehlke, and E Bayerdörffer, and N Lehn, and G A Mannes, and A Sommer, and W Höchter, and J Weingart, and E Bästlein, and R Hatz, and M Stolte
September 1997, Revista espanola de enfermedades digestivas,
S Miehlke, and E Bayerdörffer, and N Lehn, and G A Mannes, and A Sommer, and W Höchter, and J Weingart, and E Bästlein, and R Hatz, and M Stolte
December 1989, Lancet (London, England),
S Miehlke, and E Bayerdörffer, and N Lehn, and G A Mannes, and A Sommer, and W Höchter, and J Weingart, and E Bästlein, and R Hatz, and M Stolte
January 1992, The American journal of gastroenterology,
S Miehlke, and E Bayerdörffer, and N Lehn, and G A Mannes, and A Sommer, and W Höchter, and J Weingart, and E Bästlein, and R Hatz, and M Stolte
August 1991, Lancet (London, England),
S Miehlke, and E Bayerdörffer, and N Lehn, and G A Mannes, and A Sommer, and W Höchter, and J Weingart, and E Bästlein, and R Hatz, and M Stolte
January 1993, Digestive diseases and sciences,
S Miehlke, and E Bayerdörffer, and N Lehn, and G A Mannes, and A Sommer, and W Höchter, and J Weingart, and E Bästlein, and R Hatz, and M Stolte
January 1995, Scandinavian journal of gastroenterology. Supplement,
S Miehlke, and E Bayerdörffer, and N Lehn, and G A Mannes, and A Sommer, and W Höchter, and J Weingart, and E Bästlein, and R Hatz, and M Stolte
December 1995, Revista espanola de enfermedades digestivas,
S Miehlke, and E Bayerdörffer, and N Lehn, and G A Mannes, and A Sommer, and W Höchter, and J Weingart, and E Bästlein, and R Hatz, and M Stolte
January 1994, Zeitschrift fur Gastroenterologie,
S Miehlke, and E Bayerdörffer, and N Lehn, and G A Mannes, and A Sommer, and W Höchter, and J Weingart, and E Bästlein, and R Hatz, and M Stolte
November 1992, Gastroenterology,
S Miehlke, and E Bayerdörffer, and N Lehn, and G A Mannes, and A Sommer, and W Höchter, and J Weingart, and E Bästlein, and R Hatz, and M Stolte
February 1991, Journal of pediatric gastroenterology and nutrition,
Copied contents to your clipboard!